Safety and preliminary efficacy in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) receiving lisocabtagene maraleucel (Liso-cel) in TRANSCEND NHL 001 Meeting Abstract
| Authors: | Wang, M.; Gordon, L. I.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Ghosh, N.; Lunning, M. A.; Maloney, D. G.; Farazi, T. A.; Garcia, J.; Xie, B.; Newhall, K. J.; Dehner, C.; Siddiqi, T. |
| Abstract Title: | Safety and preliminary efficacy in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) receiving lisocabtagene maraleucel (Liso-cel) in TRANSCEND NHL 001 |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 428s |
| Language: | English |
| ACCESSION: | WOS:000487345806278 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7516 |
| Notes: | Meeting Abstract: 7516 -- Source: Wos |
